TONON, MARTA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.833
AS - Asia 3.123
EU - Europa 1.978
SA - Sud America 552
AF - Africa 459
Continente sconosciuto - Info sul continente non disponibili 127
OC - Oceania 66
Totale 11.138
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.502
SG - Singapore 887
IT - Italia 780
VN - Vietnam 629
CN - Cina 461
BR - Brasile 344
HK - Hong Kong 313
ES - Italia 181
BD - Bangladesh 154
FR - Francia 128
DE - Germania 108
NL - Olanda 87
GB - Regno Unito 86
IN - India 86
CA - Canada 80
FI - Finlandia 80
PL - Polonia 69
AR - Argentina 62
TR - Turchia 56
IQ - Iraq 49
SE - Svezia 48
RU - Federazione Russa 42
JP - Giappone 41
MX - Messico 36
PK - Pakistan 35
ID - Indonesia 33
ZA - Sudafrica 32
PH - Filippine 31
SA - Arabia Saudita 30
EC - Ecuador 29
JM - Giamaica 26
AL - Albania 24
CO - Colombia 24
UA - Ucraina 24
BJ - Benin 22
HR - Croazia 22
TN - Tunisia 22
AT - Austria 21
UZ - Uzbekistan 21
CL - Cile 20
EG - Egitto 20
IE - Irlanda 20
SK - Slovacchia (Repubblica Slovacca) 20
MY - Malesia 19
CH - Svizzera 18
CI - Costa d'Avorio 18
BW - Botswana 17
TT - Trinidad e Tobago 17
AU - Australia 16
IR - Iran 16
JO - Giordania 16
KG - Kirghizistan 16
NI - Nicaragua 16
NZ - Nuova Zelanda 16
TH - Thailandia 16
CR - Costa Rica 15
SI - Slovenia 15
ET - Etiopia 14
LA - Repubblica Popolare Democratica del Laos 14
LC - Santa Lucia 14
MA - Marocco 14
PE - Perù 14
PR - Porto Rico 14
PY - Paraguay 14
RO - Romania 14
VE - Venezuela 14
YE - Yemen 14
AZ - Azerbaigian 13
BE - Belgio 13
CZ - Repubblica Ceca 13
IL - Israele 13
KZ - Kazakistan 13
LB - Libano 13
LY - Libia 13
PS - Palestinian Territory 13
GH - Ghana 12
GT - Guatemala 12
HU - Ungheria 12
IS - Islanda 12
KR - Corea 12
NC - Nuova Caledonia 12
XK - ???statistics.table.value.countryCode.XK??? 12
AD - Andorra 11
AE - Emirati Arabi Uniti 11
BG - Bulgaria 11
BO - Bolivia 11
CD - Congo 11
CM - Camerun 11
CW - ???statistics.table.value.countryCode.CW??? 11
GR - Grecia 11
KE - Kenya 11
LV - Lettonia 11
MR - Mauritania 11
NE - Niger 11
RE - Reunion 11
TJ - Tagikistan 11
TW - Taiwan 11
BF - Burkina Faso 10
BS - Bahamas 10
CG - Congo 10
Totale 10.539
Salva come PNG Salva come JPEG
Città #
Ashburn 632
Singapore 548
San Jose 486
Fairfield 306
Hong Kong 285
Ho Chi Minh City 203
Hanoi 151
Woodbridge 132
Los Angeles 128
Chandler 126
Houston 123
Santa Clara 121
Seattle 119
Council Bluffs 117
Sabadell 116
Cambridge 112
Beijing 101
Ann Arbor 96
Boardman 89
New York 86
Wilmington 81
Milan 68
Rome 61
Lauterbourg 53
Dallas 49
Munich 49
Padova 46
Helsinki 43
São Paulo 42
Chicago 41
Bytom 37
Da Nang 35
Orem 35
Matadepera 34
San Diego 34
Tokyo 32
Buffalo 31
Atlanta 29
Istanbul 26
Medford 26
Phoenix 26
Princeton 26
Des Moines 24
London 24
Cotonou 22
Roxbury 22
Haiphong 21
Montreal 21
Turku 19
Abidjan 18
Hefei 18
Johannesburg 18
Kingston 18
San Francisco 18
Baghdad 17
Brooklyn 17
Tashkent 17
Tirana 17
Bishkek 16
Biên Hòa 16
Bologna 16
Chennai 16
Guangzhou 16
Redondo Beach 16
Stockholm 16
Toronto 16
Amman 15
Amsterdam 15
Dublin 15
Managua 15
Turin 15
Castries 13
Denver 13
Jakarta 13
Legnaro 13
Madrid 13
San José 13
Auckland 12
Nanjing 12
Noumea 12
Paris 12
Rio de Janeiro 12
Tunis 12
Vientiane 12
Addis Ababa 11
Andorra la Vella 11
Düsseldorf 11
Naples 11
Niamey 11
Palermo 11
Vienna 11
Warsaw 11
Accra 10
Baku 10
Dong Ket 10
Dushanbe 10
Frankfurt am Main 10
Gaborone 10
Guatemala City 10
Hải Dương 10
Totale 5.825
Salva come PNG Salva come JPEG
Nome #
Incidence and implications of abstinence-induced recompensation in alcohol-related cirrhosis 433
Development, validation, and prognostic evaluation of a risk score for long-term liver-related outcomes in the general population: a multicohort study 428
Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections 366
CARATTERIZZAZIONE CLINICA E PROGNOSTICA DEI PATTERNS DI SCOMPENSO DELLA CIRROSI EPATICA 363
Including Relative Adrenal Insufficiency in Definition and Classification of Acute-on-Chronic Liver Failure 351
The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of a randomized, controlled clinical trial 347
Validation and expansion of Baveno VII recompensation criteria in patients with cirrhosis and curable liver disease 334
Real-world experience with long-term albumin in patients with cirrhosis and ascites 320
Outcomes and Mortality of Grade 1 Ascites and Recurrent Ascites in Patients With Cirrhosis 303
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event 300
Response to Terlipressin and Albumin Is Associated With Improved Liver Transplant Outcomes in Patients With Hepatorenal Syndrome 287
Etiological cure prevents further decompensation and mortality in cirrhotic patients with ascites as the single first decompensating event 264
A new clinical and prognostic characterization of the patterns of decompensation of cirrhosis 259
Can the Multidimensional Prognostic Index (MPI) be a predictive instrument for mortality in older adult liver transplant candidates? 257
Incidence, predictors and outcomes of acute-on-chronic liver failure in outpatients with cirrhosis 249
Predictors of Early Readmission in Patients With Cirrhosis After the Resolution of Bacterial Infections. 243
Reply to: "A cut-off serum creatinine value of 1.5 mg/dl for AKI--to be or not to be". 241
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome 222
Impact of bacterial infections prior to liver transplantation on post-transplant outcomes in patients with cirrhosis 219
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis 213
Assessment of bone mineral density in patients with cirrhosis treated with third-generation nucleos(t)ide analogues: comparison between tenofovir and entecavir 208
Natural history of acute kidney disease in patients with cirrhosis 205
Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event 204
Comparison of Fondaparinux and Low-Molecular-Weight Heparin in the Treatment of Portal Vein Thrombosis in Cirrhosis 201
Development and Validation of a Scoring System That Includes Corrected QT Interval For Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding 200
Sepsis-induced acute kidney injury in patients with cirrhosis 199
The Treatment of Hepatorenal Syndrome 198
Predicting outcomes of liver transplantation in patients with NASH: pre-transplant renal function is key 196
Diagnostic and prognostic performance of urinary neutrophil gelatinase-associated lipocalin in patients with cirrhosis and acute kidney injury 190
Alcohol-related cirrhosis: The most challenging etiology of cirrhosis is more burdensome than ever 188
EASL Clinical Practice Guidelines on acute-on-chronic liver failure 187
Cardiovascular predictors of death in patients with cirrhosis 186
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 176
Cirrhosis and Portal Hypertension: How Do We Deal with Ascites and Its Consequences 165
Effects of a reorganization of cirrhosis care during the lockdown for SARS-CoV-2 outbreak 165
[Ascites and acute kidney injury] 162
The impact of age and frailty on hospitalization and survival in older liver transplant recipients: a longitudinal cohort study 144
Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial 137
Rectus femoris ultrasound identifies sarcopenia and predicts poor outcomes in patients with an acute decompensation of cirrhosis 135
Changes in the epidemiology and management of bacterial infections in cirrhosis 133
Risk of portal hypertensive complications preventable by TIPS in patients with ascites 132
Management of ascites and hepatorenal syndrome 128
Acute on chronic liver failure in cirrhosis 121
Portal Hypertension: Critical Care Considerations 119
Don't delay: Early paracentesis can save lives in hospitalized patients with cirrhosis and ascites 116
EFFICACY AND SAFETY OF TREATMENT OF ACUTE NONMALIGNANT PORTAL VEIN THROMBOSIS WITH SUBCUTANEOUS FONDAPARINUX IN PATIENTS WITH CIRRHOSIS AND MARKED THROMBOCYTOPENIA 114
Recompensation of cirrhosis in candidates of transplant: Tips and tricks for delisting 111
Efficacy and safety of treatment of acute nonmalignant portal vein thrombosis with subcutaneous fondaparinux in patients with cirrhosis and marked thrombocytopenia 111
Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis 111
Mechanisms and treatment approaches for ACLF 110
Bacterial Infections in Cirrhosis 108
Refining Prognosis in Cirrhosis Patients With Ascites: Impact of Acute vs. Non-Acute Decompensation 95
Liver Health: An Emerging Concept 71
PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study 50
Effectiveness, Safety and Patient-Reported Outcomes of Bulevirtide Therapy in Chronic Hepatitis Delta: Real-World Evidence From a Prospective Observational Study 34
Reply to: “Predicting the need for early TIPS in patients with cirrhosis and ascites: More art than science” 29
Totale 11.138
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.129
article - articoli 29.176
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 232
Totale 59.537
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022328 0 0 25 15 42 35 6 35 34 21 35 80
2022/2023317 51 15 3 35 44 40 8 20 40 5 45 11
2023/2024325 9 43 53 34 21 26 31 17 18 13 41 19
2024/20251.390 11 90 66 52 98 60 111 126 112 89 219 356
2025/20266.502 346 386 860 891 711 297 924 512 569 374 352 280
2026/20271.216 851 334 31 0 0 0 0 0 0 0 0 0
Totale 11.138